Coronavirus vaccine: AstraZeneca could expand US trial to pursue 90% efficacious vaccine
AstraZeneca’s (AZN) positive interim results for its COVID-19 vaccine Monday was met with some confusion as health experts and Wall...
Full Article
Coronavirus vaccine: AstraZeneca could expand US trial to pursue 90% efficacious vaccine
Upworthy
0 shares
1 views
You might like
Related news coverage
Moderna asking US, European regulators to OK its virus shots
SeattlePI.com
Moderna Inc. said it would ask U.S. and European regulators Monday to allow emergency use of its COVID-19 vaccine as new study..
-
Volunteer seeks investigation on Serum after developing complication but company is intimidating
Mid-Day
-
AstraZeneca says "dosing error" resulted in boosted vaccine trial outcome, justifying claims of "90 percent effective"
NaturalNews.com
-
Germany prepares to roll out vaccines soon, as cases hit 1 million
Mid-Day
-
Thailand signs supply deals for AstraZeneca COVID-19 vaccine
SeattlePI.com
Advertisement
More coverage
Nicola Sturgeon coronavirus update as vaccine blow sees trial to be re-run
Daily Record
Pharma firm AstraZeneca which is partnering the university made the admission following reports from the US that its best..
